Benzamide compounds and related methods of use

US9371277B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9371277-B2
Application numberUS-201314139763-A
CountryUS
Kind codeB2
Filing dateDec 23, 2013
Priority dateDec 21, 2012
Publication dateJun 21, 2016
Grant dateJun 21, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.

First claim

Opening claim text (preview).

We claim: 1. A compound selected from compounds of a formula wherein each of R 1 and R 2 is independently selected from phenyl, benzyl, heteroaryl, and heteroarylalkyl moieties; each of E 1 and E 2 is independently selected from CH and N, provided at least one of E 1 and E 2 is CH; A is a divalent moiety selected from carbonyl, amino, carboxamido (—C(O)NH—), imidocarbyl (—C(NH)—) and a tautomer thereof (—N ═C(NH 2 )—) with X; X is a divalent moiety selected from methylene, carbonyl, amino, and aza-substituted ethylene (—NHCH 2 —) moieties; Y is a divalent moiety selected from oxy, amino, alkylene, and aza-substituted alkylene moieties; and Z is a divalent moiety selected from sulfonyl, sulfinyl, thio, oxy, amino, and methylene moieties, providing where A is carbonyl, Z is sulfonyl and R 1 and R 2 are selected from phenyl and substituted phenyl, X is not amino or methylamino and Y is not amino, alkylamino, allylamino or benzylamino, and wherein each of R 1 , R 2 , A, X, Y and Z is optionally substituted with 1-10 substituents independently selected from halo, cyano, nitro, hydroxy, amino, alkyl, cycloalkyl, cycloheteroalkyl, aryl, arylalkyl, alkoxy, alkenyl, haloalkyl, aminoalkyl, hydroxyalkyl, alkylene, alkylsulfonyl, haloalkylsulfonyl, haloalkylsulfinyl, alkylamido, alkylsulfonamido, alkylthio, alkylcarbonyl, alkoxycarbonyl and combinations of such substituents; R 3 is selected from said substituents and combinations thereof; and n is an integer from 0-4, and salts of said compounds. 2. The compound of claim 1 where A is carbonyl and E 2 is CH, said compound of a formula 3. The compound of claim 2 wherein X is selected from amino and alkylamino moieties, and Z is methylene, said compound of a formula 4. The compound of claim 3 wherein Y is selected from oxy, alkylene, alkyl-substituted alkylene, amino and substituted amino moieties. 5. The compound of claim 4 wherein R 2 is a substituted benzyl moiety, said substituents selected from 1-3 halo and cyano substituents and combinations thereof. 6. The compound of claim 4 wherein Y is a substituted amino moiety and R 2 is selected from phenyl, substituted phenyl, benzyl, substituted benzyl, heteroaryl, substituted heteroaryl, heteroarylalkyl and substituted heteroarylalkyl moieties. 7. The compound of claim 6 wherein said amino substituent is selected from alkyl and cycloalkyl moieties. 8. The compound of claim 7 wherein said amino substituent is selected from methyl, ethyl, isopropyl and cyclopropyl moieties.

Assignees

Inventors

Classifications

  • in position 3 · CPC title

  • Amides; Imides · CPC title

  • Y being a hetero atom · CPC title

  • having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9371277B2 cover?
Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
Who is the assignee on this patent?
Univ Northwestern, Gen Hospital Corp
What technology area does this patent fall under?
Primary CPC classification C07C311/21. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).